A clinical case of drug-induced arterial hypertension caused by glycyrrhizic acid

Cover Page

Cite item

Full Text

Abstract

Background: In clinical practice, drug-induced arterial hypertension (AH) often remains undiagnosed, since the identification of an ethical disease in this form of AH avoids the initiation of antihypertensive therapy. A critical part in the differential diagnosis of hypertension and planning of long-term strategies for managing a patient requires a thorough study of the properties of the drugs taken and the pathophysiological mechanisms that depend on the increase in high blood pressure against the background of taking one or another substance.

Clinical case description: Assumption of pregnancy in a random 57-year-old Caucasian female patient with AH syndrome and history of AD crisis during the year. Against the background of two-component antihypertensive therapy, indapamide 2.5 mg + telmisartan 80 mg, increased blood pressure. From the anamnesis of life, it is noteworthy that the patient should keep records with a hepatologist; with a diagnosis of chronic viral hepatitis C with moderate activity, she takes Phosphogliv. Physical examination confirmed the presence of grade 2 hypertension; no signs of target organ detection were found. Laboratory and instrumental research showed cytolytic syndrome of minimal activity (AST, 74.8 U/l; ALT, 60.5 U/l), hypokalemia (K+ 2.1 mmol/l), unknown etiology, aldosterone within the normal range, metanephrine (80.4 pg/ml at a rate of <64 pg/ml), and normetanephrine (276 pg/ml at a rate of <176 pg/ml) in blood plasma are increased. MSCT of the kidneys and adrenal glands revealed no enlarged formations. Drug-induced arterial hypertension was clinically diagnosed. Concomitant diseases: Chronic viral hepatitis C, moderate activity. Varicose veins, venous infection of the extremities. Dynamics and outcome. After the abolition of glycyrrhizic acid, blood pressure and potassium levels in the blood plasma returned to normal, which is not recommended to take antihypertensive drugs.

Conclusion: An exceptional clinical situation is a pronounced manifestation of a rare side effect of glycyrrhizic acid in the form of drug-induced hypertension.

About the authors

Oxana N. Antropova

Altai State Medical University

Author for correspondence.
Email: antropovaon@mail.ru
ORCID iD: 0000-0002-6233-7202
SPIN-code: 3539-2790

Dr. Sci. (Med.)

Russian Federation, Barnaul

Irina V. Osipova

Altai State Medical University

Email: i.osipova@gmail.com
ORCID iD: 0000-0002-6845-6173
SPIN-code: 1904-5154

Dr. Sci. (Med.)

Russian Federation, Barnaul

Svetlana B. Silkina

Consultative and Diagnostic Institute of the Altai Territory

Email: s.shel@mail.ru
ORCID iD: 0000-0001-8282-2574
SPIN-code: 3504-5041

MD, PhD

Russian Federation, Barnaul

Lolita A. Obrazcova

Altai State Medical University

Email: mob1977@mail.ru
ORCID iD: 0000-0001-5283-4996
SPIN-code: 7677-4383
Russian Federation, Barnaul

References

  1. Остроумова О.Д., Сычев Д.А., Кочетков А.И., и др. Лекарственно-индуцированная артериальная гипертензия // Медицинский алфавит. 2022. № 3. С. 8–13. [Ostroumova O.D., Sychev D.A., Kochetkov A.I., et al. Drug-induced hypertension. Medical alphabet. 2022;(3):8–13. (In Russ).] doi: 10.33667/2078-5631-2022-3-8-13
  2. Lovell AR, Ernst ME. Drug-induced hypertension: Focus on mechanisms and management. Curr Hypertens Rep. 2017; 19(5):39. doi: 10.1007/s11906-017-0736-z
  3. Grossman A, Messerli FH, Grossman E. Drug induced hypertension: An unappreciated cause of secondary hypertension. Eur J Pharmacol. 2015;763(Pt A):15–22. doi: 10.1016/j.ejphar.2015.06.027
  4. Foy MC, Vaishnav J, Sperati CJ. Drug-induced hypertension. Endocrinol Metab Clin North Am. 2019;48(4):859–873. doi: 10.1016/j.ecl.2019.08.013
  5. Falet JP, Elkrief A, Green L. Hypertensive emergency induced by licorice tea. CMAJ. 2019;191(21):E581–E583. doi: 10.1503/cmaj.180550
  6. Sontia B, Mooney J, Gaudet L, et al. Pseudohyperaldosteronism, liquorice, and hypertension. J Clin Hypertens (Greenwich). 2008;10(2):153–157. doi: 10.1111/j.1751-7176.2008.07470.x
  7. Serra A, Uehlinger DE, Ferrari P, et al. Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol. 2002;13(1):191–196. doi: 10.1681/ASN.V131191
  8. Deutch MR, Grimm D, Wehland M, et al. Bioactive candy: Effects of licorice on the cardiovascular system. Foods. 2019; 8(10):495. doi: 10.3390/foods8100495
  9. Rajewski P, Zarębska-Michaluk D, Janczewska E, et al. Hepatitis C infection as a risk factor for hypertension and cardiovascular diseases: An EpiTer multicenter study. J Clin Med. 2022;11(17):5193. doi: 10.3390/jcm11175193
  10. Petta S. Hepatitis C virus and cardiovascular: A review. J Adv Res. 2017;8(2):161–168. doi: 10.1016/j.jare.2016.06.001

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies